Earnings
ResMed Stops Selling Astral Ventilator, Takes $42 Million Reserve And Vows 'Best Recall' Ever
The decision costs about $75 million in full-year revenue, the CFO said, as life support device sales fell 94% in the Americas.
RMD
ResMed (RMD) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
ResMed's Marketing Push Added Nothing To Sales Last Quarter, CEO Says — 'Not Yet'
ResMed held its 5% to 7% growth outlook after a 7% quarter, and management said the midpoint remains the most likely result.
Earnings
ResMed Buys Back $936 Million Of Stock In One Quarter, Holds Its Full-Year Outlook
The sleep-device maker's adjusted earnings rose 14% to $2.91 a share, with more than $1.0 billion returned to holders.